Location
Medical Sciences Divisional Office
University of Oxford
Level 3, John Radcliffe Hospital
Oxford OX3 9DU
Gavin Screaton
Head of Medical Sciences Division
The Head of Division is responsible for maintaining and further developing the international reputation of Medical Sciences in both research and teaching. He provides vision and leadership across all aspects of the Division's activities including divisional research strategy, educational policy and standards, the recruitment and retention of outstanding academics, relationships with external funding agencies, interactions with local NHS Foundation Trusts, fundraising, improving diversity and equality, and the use of resources. He works closely with the heads of the 16 departments within the Division and the other University academic divisions to foster strong interdisciplinary links across the spectrum of academic activity and with the colleges to help maintain excellence in teaching for undergraduate and graduate courses.
The Head of Division is a member of University Council and its major committees, which are responsible for determining overall university strategy.
Prior to being appointed as the Head of the Medical Sciences Division, Professor Screaton was Dean of the Faculty of Medicine, Imperial College.
Recent publications
-
Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study
Moore S. et al, (2022)
-
Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a Single, Sequence-Guided Deep Generative Framework
Chenthamarakshan V. et al, (2022)
-
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022)
-
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Journal article
Nutalai R. et al, (2022), Cell
-
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Journal article
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219